BiotechTube
Home/Vir Biotechnology/Vanina de Verneuil
VD

Vanina de Verneuil

Executive Vice President, General Counsel and Corporate Secretary

Vir Biotechnology

Therapeutic Areas

Infectious DiseasesOncologyImmunology

Vir Biotechnology Pipeline

DrugIndicationPhase
VIR-2218 + VIR-3434 (Combination)Chronic Hepatitis Delta (HDV)Phase 3
PRO-XTEN® Platform CandidatesUndisclosed Oncology IndicationsPre-clinical

Leadership Team at Vir Biotechnology

MD
Marianne De Backer
President, Chief Executive Officer and Director
JC
Jeff Calcagno
Executive Vice President and Chief Business Officer
ME
Mark Eisner
Executive Vice President and Chief Medical Officer
MH
Maninder Hora
Executive Vice President and Chief Technical Operations Officer
JO
Jason O’Byrne
Executive Vice President and Chief Financial Officer
JE
Jennifer Eileen Towne
Executive Vice President and Chief Scientific Officer
TM
Toby Medaris
Senior Vice President Human Resources
CW
Carolyn Wang
Senior Vice President Corporate Communications
AL
Antonio Lanzavecchia
Senior Vice President and Senior Research Fellow
VS
Vicki Sato
Chairman of the Board
View full Vir Biotechnology profile